FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; 5Chang Gung University College of Medicine, Taoyuan, TW; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; 8Department of Dermatology and Population Health Sciences, King’s College London, London, UK; 9Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; 11Eli Lilly and Company, Indianapolis, Indiana,US; 12Almirall R&D, S.A., Barcelona, ES; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US
244PDF: 78 -
Skin reaction to COVID-19 vaccine: a report of 4 cases
1150PDF: 503HTML: 25 -
Isotretinoin musculoskeletal side effects: a systematic review
6383PDF: 1245SUPPLEMENTARY: 481HTML: 521 -
Orofacial granulomatosis in children can be the initial manifestation of systemic disease: a presentation of two cases
3041PDF: 971SUPPLEMENTARY TABLE 1: 334HTML: 2782 -
Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument
1243PDF: 406APPENDIX S1: 226HTML: 20 -
Proteus syndrome: a case report and a case study review in China
11945PDF: 979HTML: 2070 -
Pityriasis rosea manifesting only with a herald patch
535PDF: 332HTML: 27 -
10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain
231PDF: 161 -
Seasonal onychomadesis in an elderly gentleman
2325PDF: 843HTML: 21634 -
En coup de sabre morphea: an uncommon condition in Africa
1299PDF: 535HTML: 78 -
A bibliometric study of the top 100 most-cited articles on melanoma: insights into research trends and characteristics
621PDF: 348SUPPLEMENTARY MATERIAL: 194HTML: 22 -
Telangiectasia Macularis Eruptiva Perstans: more than skin deep
11846PDF: 2277HTML: 2307 -
True leukonychia: case reports and review of the literature
490PDF: 463SUPPLEMENTARY MATERIAL: 41HTML: 17 -

